PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.10%
Revenue growth at 50-75% of MAXN's 9.44%. Martin Whitman would worry about competitiveness or product relevance.
15.31%
Gross profit growth above 1.5x MAXN's 4.84%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
44.28%
Positive EBIT growth while MAXN is negative. John Neff might see a substantial edge in operational management.
23.57%
Positive operating income growth while MAXN is negative. John Neff might view this as a competitive edge in operations.
42.88%
Positive net income growth while MAXN is negative. John Neff might see a big relative performance advantage.
34.48%
Positive EPS growth while MAXN is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
34.48%
Positive diluted EPS growth while MAXN is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.29%
Share reduction more than 1.5x MAXN's 9.11%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.29%
Slight or no buyback while MAXN is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
87.22%
Similar OCF growth to MAXN's 87.83%. Walter Schloss would assume comparable operations or industry factors.
77.66%
FCF growth above 1.5x MAXN's 32.52%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-44.47%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-16.93%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
27.52%
Positive 3Y CAGR while MAXN is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
81.97%
10Y OCF/share CAGR at 75-90% of MAXN's 92.49%. Bill Ackman would demand strategic changes to close the gap in long-term cash generation.
88.61%
5Y OCF/share CAGR is similar to MAXN's 92.49%. Walter Schloss might see parallel cost profiles or expansions producing comparable cash flow.
-181.21%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-210.21%
Negative 10Y net income/share CAGR while MAXN is at 97.72%. Joel Greenblatt sees a major red flag in long-term profit erosion.
94.38%
5Y net income/share CAGR similar to MAXN's 97.72%. Walter Schloss might see both on parallel mid-term trajectories.
-256.41%
Negative 3Y CAGR while MAXN is 98.47%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-65.63%
Negative equity/share CAGR over 10 years while MAXN stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
1001.41%
Equity/share CAGR of 1001.41% while MAXN is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
1362.76%
Positive short-term equity growth while MAXN is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.28%
AR growth is negative/stable vs. MAXN's 47.19%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
11.05%
Inventory growth well above MAXN's 10.39%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
5.45%
Asset growth well under 50% of MAXN's 14.74%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
-5.37%
We have a declining book value while MAXN shows 237.57%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
22.31%
We have some new debt while MAXN reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-10.20%
Our R&D shrinks while MAXN invests at 17.48%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-8.99%
We cut SG&A while MAXN invests at 11.16%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.